To assess more definitively the inhibitory effect of ANXA2 on the frameshifting of IBV pseudoknot RNA, we used a prostate cancer cell line, LNCaP, which does not express endogenous ANXA2 protein in the cells. The gene discussed is ANXA2; the disease is prostate cancer.